Publication at Faculty of Medicine in Hradec Králové |
2019
Abstract
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system affecting most commonly young adults. There has been tremendous progress in the treatment of relapsing-remitting MS over recent years.
The concept of early treatment to achieve better outcomes in MS has clearly emerged, fully supported by the positive results of several randomised clinical trials. The heterogenity of the disease course in MS remains a challenge for patient management.
The paper deals with two different therapeutic approaches usen in MS - escalation and induction therapy in the ra of expanding treatment options.